Editas Medicine (EDIT) Times Interest Earned (2025)

Editas Medicine (EDIT) has reported Times Interest Earned for 11 consecutive years, with -$10.23 the latest figure, recorded in Q3 2025.

• In Q3 2025, Times Interest Earned changed N/A year-over-year to -$10.23; the TTM figure through Sep 2025 stood at -$24.83 (up 22.07% YoY), while the FY2024 annual figure was -$0.65, down 25.41% from the prior year.
• Times Interest Earned advanced to -$10.23 in Q3 2025 per EDIT's latest filing, from -$20.58 in the prior quarter.
• Across five years, Times Interest Earned topped out at $22.11 in Q4 2022 and bottomed at -$229.52 in Q4 2024.
• Historically, Times Interest Earned has averaged -$16.23 across 5 years, with a median of -$0.73 in 2021.
• Annual changes were most pronounced in 2022 — Times Interest Earned jumped 310.19% — and 2024, when it plunged 7981.55%.
• Editas Medicine's Times Interest Earned stood at $5.39 in 2021, then surged by 310.19% to $22.11 in 2022, then plunged by 132.59% to -$7.21 in 2023, then tumbled by 3084.88% to -$229.52 in 2024, then surged by 95.54% to -$10.23 in 2025.
• Business Quant data shows EDIT's Times Interest Earned at -$10.23 in Q3 2025, -$20.58 in Q2 2025, and -$14.09 in Q1 2025.